Rheumatoid arthritis RA-BEACON illuminates baricitinib

This entry was posted by ctbenefits on April 15, 2016 at 5:46 pm

Rheumatoid arthritis RA-BEACON illuminates baricitinib

Baricitinib therapy has demonstrated clinical efficacy in patients with rheumatoid arthritis (RA), according to the results of the RA-BEACON phase 3 trial just published in the New England Journal of Medicine. “Baricitinib works well in patients who …

(Visited 3 times, 1 visits today)
Click here to read the full article
3
Like
Save

Comments

Write a comment

*